Evidence-based educational resources for healthcare providers on cancer genomic topics.
Hereditary Breast and Ovarian Cancer
Point of care tool: A two-part (I, II) tool to identify individuals likely to benefit from a genomic risk assessment (I) and those predicted to be at increased risk to carry a mutation in the BRCA1 or BRCA2 genes (II). (April 2025)
GECKO on the run: A 4-page, evidence-based summary for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (October 2023)
GECKO deep dive: A 16-page, comprehensive evidence-based resource for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more. (September 2023)
Lynch Syndrome (Hereditary colorectal and endometrial cancer)
Point of care tool: Three point of care tools featuring who to consider for genetic referral, gene specific cancer risks and gene specific screening recommendations. (Updated Sept 2025).
GECKO on the run: A 3-page, evidence-based summary for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (Updated Jan 2019)
GECKO deep dive: An 11-page, comprehensive evidence-based resource for healthcare pracitioners. Features a bottom line, red flags for a genomic assessment, gene specific cancer risks, benefits and considerations of genetic testing, somatic vs germline testing, gene specific screening and surveillance recommendations and more. (Updated Sept 2025)
General Hereditary Cancer
Point of care tool: Red Flags (7) to identify those with risk of a Hereditary Cancer Syndrome most likely to benefit from a referral to genetics. *version français disponible* (updated July 2024)
Hereditary Renal Cell Carcinoma
Point of care tool: Outlines how to identify those patients most likely to benefit from referral to genetics for assessment of a hereditary renal cell cancer syndrome including brief summary of renal cell carcinoma syndromes. (January 2023)
